Table 3 Therapeutic efficacy in different BALB/c groups
Groups | n | Therapeutic efficacy (%) | |
|---|---|---|---|
Mean ± SD using Digimizer results | Mean ± SD using CT scan results | ||
CEI1: treated with curcumin nanoemulsion (CUR-NE) (40 mg/kg/day) | 6 | 55.16 ± 32.37 | 24.6 ± 26.89 |
CEI2: treated with CUR-NE (20 mg/kg/day) | 6 | 26.34 ± 26.77 | -8.19 ± 28.97 |
CEI3: treated with NE without CUR (NE-no CUR) | 6 | 15.01 ± 37.34 | -48.03 ± 41.31 |
CEI4: treated with curcumin suspension (CUR-S) (40 mg/kg/day) | 6 | 47.28 ± 30.77 | 2.48 ± 12.17 |
CEI5: treated with ABZ (150 mg/kg/day) (PC1) | 6 | 25.11 ± 30.11 | 8.66 ± 7.85 |
CEI6: received sterile PBS (NC2) | 4 | nc* | -15.49 ± 5.45 |